Photo of David Beasley

View Scopus Profile

David Beasley, PhD

Associate Director, World Health Organization Collaborating Center

  • 3820 Citations
  • 36 h-Index
19972020

Research output per year

If you made any changes in Pure these will be visible here soon.

Personal profile

Personal profile

Member, Institute for Human Infections & Immunity

Fingerprint Dive into the research topics where David Beasley is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 28 Similar Profiles

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Projects

Immunomodulatory Effects of Heterochiral Biomaterials

Beasley, D.

Washington University in St Louis

2/20/19 → 10/31/22

Project: Other project

Immunomodulatory Effects of Heterochiral Biomaterials

Beasley, D.

2/20/19 → 10/31/22

Project: Other project

Pre-Clinical Models of Infectious Diseases - Part A: Small Animal Models of Infectious Diseases

Beasley, D.

National Inst of Allergy & Infectious Di

7/14/17 → 10/31/21

Project: Other project

Pre-Clinical Models of Infectious Diseases - Part A: Small Animal Models of Infectious Diseases

Beasley, D.

National Inst of Allergy & Infectious Di

7/14/17 → 10/31/21

Project: Other project

Pre-Clinical Models of Infectious Diseases - Part C: Non-Traditional and Animal Replacement Models of Infectious Diseases

Beasley, D.

National Inst of Allergy & Infectious Di

7/14/17 → 7/13/24

Project: Other project

Research Output

New international guidance on quality, safety and efficacy of DNA vaccines

Beasley, D. W. C., Dec 1 2020, In : npj Vaccines. 5, 1, 53.

Research output: Contribution to journal › Comment/debate

Open Access

Publisher Correction: New international guidance on quality, safety and efficacy of DNA vaccines (npj Vaccines, (2020), 5, 1, (53), 10.1038/s41541-020-0199-0)

Beasley, D. W. C., Dec 1 2020, In : npj Vaccines. 5, 1, 62.

Research output: Contribution to journal › Comment/debate

Open Access

    • Defining a correlate of protection for chikungunya virus vaccines

    Milligan, G. N., Schnierle, B. S., McAuley, A. & Beasley, D. W. C., Nov 28 2019, In : Vaccine. 37, 50, p. 7427-7436 10 p.

    Research output: Contribution to journal › Article

    • 4 Scopus citations

    Baseline mapping of Lassa fever virology, epidemiology and vaccine research and development review-article

    Hallam, H. J., Hallam, S., Rodriguez, S., Barrett, A., Beasley, D., Chua, A., Ksiazek, T., Milligan, G., Sathiyamoorthy, V. & Reece, L. M., Dec 1 2018, In : npj Vaccines. 3, 1, 11.

    Research output: Contribution to journal › Article

    • 31 Scopus citations

    Current status of Severe Fever with Thrombocytopenia Syndrome vaccine development

    Reece, L. M., Beasley, D., Milligan, G., Sarathy, V. & Barrett, A., Apr 1 2018, In : Current Opinion in Virology. 29, p. 72-78 7 p.

    Research output: Contribution to journal › Review article

    • 7 Scopus citations